m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00148)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
GAS5
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | The GAS5-AS1 expression in cervical cancer tissues was markedly decreased when compared with that in the adjacent normal tissues. GAS5-AS1 interacted with the tumor suppressor Growth arrest specific 5 (GAS5), and increased its stability by interacting with RNA demethylase ALKBH5 and decreasing GAS5 N6-methyladenosine (m6A) modification. m6A-mediated GAS5 RNA degradation relied on the m6A reader protein YTHDF2-dependent pathway. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Cervical cancer | ICD-11: 2C77 | ||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 | |
Normal cervical epithelium cell line (HCvEpC) (Isolated from cervical tissue) | ||||
In-vivo Model | 200 uL PBS containing 1×107 cells of stable cells were subcutaneously injected into male BALB/c athymic nude mice (6-week old, 18-20 g). | |||
YTH domain-containing family protein 2 (YTHDF2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | The GAS5-AS1 expression in cervical cancer tissues was markedly decreased when compared with that in the adjacent normal tissues. GAS5-AS1 interacted with the tumor suppressor Growth arrest specific 5 (GAS5), and increased its stability by interacting with RNA demethylase ALKBH5 and decreasing GAS5 N6-methyladenosine (m6A) modification. m6A-mediated GAS5 RNA degradation relied on the m6A reader protein YTHDF2-dependent pathway. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Cervical cancer | ICD-11: 2C77 | ||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 | |
Normal cervical epithelium cell line (HCvEpC) (Isolated from cervical tissue) | ||||
In-vivo Model | 200 uL PBS containing 1×107 cells of stable cells were subcutaneously injected into male BALB/c athymic nude mice (6-week old, 18-20 g). | |||
YTH domain-containing family protein 3 (YTHDF3) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
Response Summary | A new mechanism for m6A-induced decay of Growth arrest specific 5 (GAS5) on YAP signaling in progression of Colorectal cancer which offers a promising approach for CRC treatment. LncRNA GAS5 expressions is negatively correlated with YAP and YTHDF3 protein levels in tumors from CRC patients. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Colorectal cancer | ICD-11: 2B91 | ||
Pathway Response | Hippo signaling pathway | hsa04390 | ||
Cell Process | Ubiquitination degradation | |||
In-vitro Model | DLD-1 | Colon adenocarcinoma | Homo sapiens | CVCL_0248 |
HCT 116 | Colon carcinoma | Homo sapiens | CVCL_0291 | |
HT29 | Colon cancer | Mus musculus | CVCL_A8EZ | |
LoVo | Colon adenocarcinoma | Homo sapiens | CVCL_0399 | |
LS174T | Colon adenocarcinoma | Homo sapiens | CVCL_1384 | |
RKO | Colon carcinoma | Homo sapiens | CVCL_0504 | |
SW480 | Colon adenocarcinoma | Homo sapiens | CVCL_0546 | |
SW620 | Colon adenocarcinoma | Homo sapiens | CVCL_0547 | |
Colorectal cancer [ICD-11: 2B91]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [2] | |||
Response Summary | A new mechanism for m6A-induced decay of Growth arrest specific 5 (GAS5) on YAP signaling in progression of Colorectal cancer which offers a promising approach for CRC treatment. LncRNA GAS5 expressions is negatively correlated with YAP and YTHDF3 protein levels in tumors from CRC patients. | |||
Responsed Disease | Colorectal cancer [ICD-11: 2B91] | |||
Target Regulator | YTH domain-containing family protein 3 (YTHDF3) | READER | ||
Target Regulation | Down regulation | |||
Pathway Response | Hippo signaling pathway | hsa04390 | ||
Cell Process | Ubiquitination degradation | |||
In-vitro Model | DLD-1 | Colon adenocarcinoma | Homo sapiens | CVCL_0248 |
HCT 116 | Colon carcinoma | Homo sapiens | CVCL_0291 | |
HT29 | Colon cancer | Mus musculus | CVCL_A8EZ | |
LoVo | Colon adenocarcinoma | Homo sapiens | CVCL_0399 | |
LS174T | Colon adenocarcinoma | Homo sapiens | CVCL_1384 | |
RKO | Colon carcinoma | Homo sapiens | CVCL_0504 | |
SW480 | Colon adenocarcinoma | Homo sapiens | CVCL_0546 | |
SW620 | Colon adenocarcinoma | Homo sapiens | CVCL_0547 | |
Cervical cancer [ICD-11: 2C77]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | The GAS5-AS1 expression in cervical cancer tissues was markedly decreased when compared with that in the adjacent normal tissues. GAS5-AS1 interacted with the tumor suppressor Growth arrest specific 5 (GAS5), and increased its stability by interacting with RNA demethylase ALKBH5 and decreasing GAS5 N6-methyladenosine (m6A) modification. m6A-mediated GAS5 RNA degradation relied on the m6A reader protein YTHDF2-dependent pathway. | |||
Responsed Disease | Cervical cancer [ICD-11: 2C77] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 | |
Normal cervical epithelium cell line (HCvEpC) (Isolated from cervical tissue) | ||||
In-vivo Model | 200 uL PBS containing 1×107 cells of stable cells were subcutaneously injected into male BALB/c athymic nude mice (6-week old, 18-20 g). | |||
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | The GAS5-AS1 expression in cervical cancer tissues was markedly decreased when compared with that in the adjacent normal tissues. GAS5-AS1 interacted with the tumor suppressor Growth arrest specific 5 (GAS5), and increased its stability by interacting with RNA demethylase ALKBH5 and decreasing GAS5 N6-methyladenosine (m6A) modification. m6A-mediated GAS5 RNA degradation relied on the m6A reader protein YTHDF2-dependent pathway. | |||
Responsed Disease | Cervical cancer [ICD-11: 2C77] | |||
Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 |
Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 | |
Normal cervical epithelium cell line (HCvEpC) (Isolated from cervical tissue) | ||||
In-vivo Model | 200 uL PBS containing 1×107 cells of stable cells were subcutaneously injected into male BALB/c athymic nude mice (6-week old, 18-20 g). | |||
References